Skip to Content
Merck
  • Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer.

Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer.

Bioorganic & medicinal chemistry letters (2006-11-11)
Min Wang, Gabrielle Lacy, Mingzhang Gao, Kathy D Miller, George W Sledge, Qi-Huang Zheng
ABSTRACT

Aromatase is a particularly good target in the treatment of estrogen receptor positive breast cancer. Novel carbon-11 labeled sulfonanilide analogues, N-[11C]methyl-N-(2-alkyloxy-4-nitrophenyl)-methanesulfonamides ([11C]3a-f, alkyl=propyl, isopropyl, 1-ethyl-propyl, cyclopentyl, cyclohexyl, and cyclohexylethyl), were designed and synthesized as potential PET agents for imaging of aromatase in breast cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-Bromo-2-cyclohexylethane, 98%